Which of the COVID-19 patients would benefit from
anticoagulant treatment?
Prophylactic low molecular weight
heparin, or heparin, has been recommended by the WHO in severe to
critically ill COVID-19 patients.125 However, the
International Society on Thrombosis and Haemostasis recommended that all
hospitalized COVID-19 patients, not just those in ICU, should receive
prophylactic low molecular weight heparin in the absence of
contraindications.158